Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201


Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.

Knutsen AP, Wall DA.

J Allergy Clin Immunol. 1999 May;103(5 Pt 1):823-32.


Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.

Haddad E, Landais P, Friedrich W, Gerritsen B, Cavazzana-Calvo M, Morgan G, Bertrand Y, Fasth A, Porta F, Cant A, Espanol T, Müller S, Veys P, Vossen J, Fischer A.

Blood. 1998 May 15;91(10):3646-53.


Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.

Hartnett BJ, Yao D, Suter SE, Ellinwood NM, Henthorn PS, Moore PE, McSweeney PA, Nash RA, Brown JD, Weinberg KI, Felsburg PJ.

Biol Blood Marrow Transplant. 2002;8(4):188-97.


Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.

Bielorai B, Trakhtenbrot L, Amariglio N, Rothman R, Tabori U, Dallal I, Golan H, Neumann Y, Reichart M, Kaplinsky C, Rechavi G, Toren A.

Bone Marrow Transplant. 2004 Aug;34(4):317-20.


Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation.

Dror Y, Gallagher R, Wara DW, Colombe BW, Merino A, Benkerrou M, Cowan MJ.

Blood. 1993 Apr 15;81(8):2021-30.


Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.

O'Marcaigh AS, DeSantes K, Hu D, Pabst H, Horn B, Li L, Cowan MJ.

Bone Marrow Transplant. 2001 Apr;27(7):703-9.


The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.

Chang YJ, Xu LP, Liu DH, Liu KY, Han W, Chen YH, Wang Y, Chen H, Wang JZ, Zhang XH, Zhao XY, Huang XJ.

Pediatr Blood Cancer. 2009 Dec;53(6):1100-6. doi: 10.1002/pbc.22159.


Reconstitution of T-cell compartment after in utero stem cell transplantation: analysis of T-cell repertoire and thymic output.

Pirovano S, Notarangelo LD, Malacarne F, Mazzolari E, Porta F, Lanfranchi A, Giliani S, Zucca S, Pecorelli S, Albertini A, Ugazio AG, Imberti L.

Haematologica. 2004 Apr;89(4):450-61.


Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.

Cowan MJ, Neven B, Cavazanna-Calvo M, Fischer A, Puck J.

Biol Blood Marrow Transplant. 2008 Jan;14(1 Suppl 1):73-5. doi: 10.1016/j.bbmt.2007.10.017. Review. Erratum in: Biol Blood Marrow Transplant. 2008 Nov;14(11):1317-8.


Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency.

Borghans JA, Bredius RG, Hazenberg MD, Roelofs H, Jol-van der Zijde EC, Heidt J, Otto SA, Kuijpers TW, Fibbe WE, Vossen JM, Miedema F, van Tol MJ.

Blood. 2006 Jul 15;108(2):763-9.


Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency.

Martín-Hernández MP, Arrieta R, Martínez A, García P, Jimenez-Yuste V, Hernandez-Navarro F.

Bone Marrow Transplant. 1997 Nov;20(9):797-9. Erratum in: Bone Marrow Transplant 1998 Apr;21(7):743.


CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.

Kasow KA, Sims-Poston L, Eldridge P, Hale GA.

Biol Blood Marrow Transplant. 2007 May;13(5):608-14. Epub 2007 Mar 23.


High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia.

Gunn N, Damon L, Varosy P, Navarro W, Martin T, Ries C, Linker C.

Biol Blood Marrow Transplant. 2003 Oct;9(10):643-8.


Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.

Yoon DH, Sohn BS, Jang G, Kim EK, Kang BW, Kim C, Kim JE, Kim S, Lee DH, Lee JS, Park SJ, Park CJ, Huh J, Suh C.

Transfusion. 2009 Sep;49(9):1890-900. doi: 10.1111/j.1537-2995.2009.02202.x. Epub 2009 May 11.


Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses.

Terakura S, Azuma E, Murata M, Kumamoto T, Hirayama M, Atsuta Y, Kodera Y, Yazaki M, Naoe T, Kato K.

Biol Blood Marrow Transplant. 2007 Jul;13(7):822-30. Epub 2007 Apr 30.


Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.

Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012.


Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.

Chang YJ, Xu LP, Liu DH, Liu KY, Han W, Chen YH, Yu-Wang, Chen H, Wang JZ, Zhang XH, Zhao XY, Huang XJ.

Biol Blood Marrow Transplant. 2009 May;15(5):632-8. doi: 10.1016/j.bbmt.2009.02.001.


G-CSF-mobilized haploidentical peripheral blood stem cell transplantation in children with poor prognostic nonmalignant disorders.

Arpaci F, Tezcan I, Kuzhan O, Yalman N, Uckan D, Kürekci AE, Ikincioğullari A, Ozet A, Tanyeli A.

Am J Hematol. 2008 Feb;83(2):133-6.

Supplemental Content

Support Center